La terapia con testosterone in uomini ipogonadici previene la progressione da prediabete a diabete tipo 2: dati da uno studio di registro di otto anni
Crossref DOI link: https://doi.org/10.1007/s40619-019-00568-3
Published Online: 2019-04-11
Published Print: 2019-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ferlin, Alberto
Text and Data Mining valid from 2019-04-01
Article History
First Online: 11 April 2019